COVID-19 Vaccines - Gabon

  • Gabon
  • The COVID-19 Vaccines market in Gabon is expected to generate a revenue of US$1.22m in 2024.
  • This projection indicates a significant growth potential for the market.
  • Furthermore, it is anticipated that the market will continue to expand at an annual growth rate (CAGR 2024-2029) of -18.45%, leading to a market volume of US$0.44m by 2029.
  • When compared to other countries, United States is projected to generate the highest revenue in the global COVID-19 Vaccines market, reaching US$4,389,000.00k in 2024.
  • This demonstrates the significant market dominance of the United States in this sector.
  • Gabon has shown a strong commitment to vaccinating its population against COVID-19, with a focus on reaching remote and underserved areas.

Key regions: United Kingdom, Germany, France, South Korea, Italy

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The COVID-19 Vaccines market in Gabon is developing at a steady pace with a growing demand for vaccines across the country.

Customer preferences:
As the COVID-19 pandemic continues to spread across the world, the demand for vaccines has been on the rise. Gabon is no exception to this trend, with a growing number of people seeking vaccination to protect themselves from the virus. The government has been actively promoting vaccination campaigns, and there is a high level of awareness among the population regarding the importance of getting vaccinated.

Trends in the market:
The COVID-19 Vaccines market in Gabon is witnessing a surge in demand for vaccines, with more and more people seeking vaccination to protect themselves from the virus. The government has been actively promoting vaccination campaigns across the country, and there is a growing awareness among the population regarding the importance of getting vaccinated. The market is dominated by a few major players who are supplying vaccines to the country. However, there is also a growing interest among local manufacturers to produce vaccines locally, which could potentially lead to a more competitive market in the future.

Local special circumstances:
Gabon has a relatively small population, which means that the demand for vaccines is not as high as in some other countries. However, the country has a high level of awareness regarding the importance of vaccination, which has led to a growing demand for vaccines. The government has been actively promoting vaccination campaigns across the country, and there is a strong public health infrastructure in place to support the vaccination drive.

Underlying macroeconomic factors:
Gabon is a relatively stable economy with a strong focus on the oil sector. The country has been hit hard by the COVID-19 pandemic, with a significant decline in oil prices leading to a slowdown in economic activity. However, the government has been actively promoting vaccination campaigns and investing in public health infrastructure to mitigate the impact of the pandemic. This has led to a growing demand for vaccines, which is expected to continue in the coming months. Overall, the COVID-19 Vaccines market in Gabon is developing at a steady pace, with a growing demand for vaccines across the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)